Cardiosome mediated regulation of MMP9 in diabetic heart: Role of mir29b and mir455 in exercise

Journal of Cellular and Molecular Medicine

Volumn 19, Issue 9, 2015, Pages 2153-2161

  Chaturvedi, Pankaj ^a   Kalani, Anuradha ^a   Medina, Ilza ^a   Familtseva, Anastasia ^a   Tyagi, Suresh C ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Cardiosomes; Diabetes; Exercise; Exosomes; Matrix metalloproteases; MicroRNAs

Indexed keywords

ACETYLCHOLINESTERASE; CD81 ANTIGEN; FLOTILLIN 1; GELATINASE B; MICRORNA; MICRORNA 29B; MICRORNA 323 5P; MICRORNA 455; MICRORNA 466; TUMOR SUSCEPTIBILITY GENE 101 PROTEIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; FLOTILLINS; MEMBRANE PROTEIN; MIRN29 MICRORNA, MOUSE; MIRN455 MICRORNA, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DIABETIC CARDIOMYOPATHY; DOWN REGULATION; ELECTRON MICROSCOPY; EXERCISE; EXOSOME; FLOW CYTOMETRY; HEART MUSCLE CELL; IMMUNOHISTOCHEMISTRY; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; ZYMOGRAPHY; ANIMAL; CARDIAC MUSCLE; CARDIAC MUSCLE CELL; ENZYMOLOGY; GENETICS; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; ULTRASTRUCTURE;

ACETYLCHOLINESTERASE; ANIMALS; ANTIGENS, CD81; BASE SEQUENCE; BIOMARKERS; DIABETES MELLITUS, TYPE 2; DOWN-REGULATION; EXOSOMES; FLOW CYTOMETRY; MATRIX METALLOPROTEINASE 9; MEMBRANE PROTEINS; MICE; MICRORNAS; MOLECULAR SEQUENCE DATA; MYOCARDIUM; MYOCYTES, CARDIAC; PHYSICAL CONDITIONING, ANIMAL;

EID: 84938764391     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12589     Document Type: Article

References (39)

1. Fiuza-Luces C, Garatachea N, Berger NA, et al. Exercise is the real polypill. Physiology. 2013; 28: 330-58.
2. Shon SM, Park JH, Nahrendorf M, et al. Exercise attenuates matrix metalloproteinase activity in preexisting atherosclerotic plaque. Atherosclerosis. 2011; 216: 67-73.
3. Moshal KS, Rodriguez WE, Sen U, et al. Targeted deletion of MMP-9 attenuates myocardial contractile dysfunction in heart failure. Physiol Res. 2008; 57: 379-84.
4. Mishra PK, Chavali V, Metreveli N, et al. Ablation of MMP9 induces survival and differentiation of cardiac stem cells into cardiomyocytes in the heart of diabetics: a role of extracellular matrix. Can J of Physiol and Pharmacol. 2012; 90: 353-60.
5. Kalani A, Kamat PK, Chaturvedi P, et al. Curcumin-primed exosomes mitigate endothelial cell dysfunction during hyperhomocysteinemia. Life Sci. 2014; 107: 1-7.
6. Kalani A, Tyagi A, Tyagi N. Exosomes: mediators of neurodegeneration, neuroprotection and therapeutics. Mol Neurobiol. 2014; 49: 590-600.
7. Fertig ET, Gherghiceanu M, Popescu LM. Extracellular vesicles release by cardiac telocytes: electron microscopy and electron tomography. J Cell Mol Med. 2014; 18: 1938-43.
8. Cretoiu D, Hummel E, Zimmermann H, et al. Human cardiac telocytes: 3D imaging by FIB-SEM tomography. J Cell Mol Med. 2014; 18: 2157-64.
9. Barile L, Lionetti V, Cervio E, et al. Extracellular vesicles from human cardiac progenitor cells inhibit cardiomyocyte apoptosis and improve cardiac function after myocardial infarction. Cardiovasc Res. 2014; 103: 530-41.
10. Ibrahim AG, Cheng K, Marban E. Exosomes as critical agents of cardiac regeneration triggered by cell therapy. Stem cell reports. 2014; 2: 606-19.
11. Sahoo S, Losordo DW. Exosomes and cardiac repair after myocardial infarction. Circ Res. 2014; 114: 333-44.
12. Waldenstrom A, Ronquist G. Role of exosomes in myocardial remodeling. Circ Res. 2014; 114: 315-24.
13. Centers for Disease Control and Prevention. National Diabetes Factsheet: national estimates and general information on diabetes and prediabetes in the United States. Atlanta, GA: Department of Health and Human Services, Centers for Disease Control and Prevention; 2011.
14. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010; 87: 4-14.
15. Moldovan L, Batte K, Wang Y, et al. Analyzing the circulating microRNAs in exosomes/extracellular vesicles from serum or plasma by qRT-PCR. Methods Mol Biol. 2013; 1024: 129-45.
16. Aoi W, Sakuma K. Does regulation of skeletal muscle function involve circulating microRNAs? Front Physiol. 2014; 5: 39.
17. Wang X, Huang W, Liu G, et al. Cardiomyocytes mediate anti-angiogenesis in type 2 diabetic rats through the exosomal transfer of miR-320 into endothelial cells. J Mol Cell Cardiol. 2014; 74: 139-50.
18. Malik ZA, Kott KS, Poe AJ, et al. Cardiac myocyte exosomes: stability, HSP60, and proteomics. Am J Physiol Heart Circ Physiol. 2013; 304: H954-65.
19. Tyagi SC, Kumar SG, Haas SJ, et al. Post-transcriptional regulation of extracellular matrix metalloproteinase in human heart end-stage failure secondary to ischemic cardiomyopathy. J Mol Cell Cardiol. 1996; 28: 1415-28.
20. Mujumdar VS, Smiley LM, Tyagi SC. Activation of matrix metalloproteinase dilates and decreases cardiac tensile strength. Int J Cardiol. 2001; 79: 277-86.
21. Kundu S, Pushpakumar SB, Tyagi A, et al. Hydrogen sulfide deficiency and diabetic renal remodeling: role of matrix metalloproteinase-9. Am J Physiol Endocrinol Metab. 2013; 304: E1365-78.
22. Hu J, Van den Steen PE, Sang QX, et al. Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases. Nat Rev Drug Discov. 2007; 6: 480-98.
23. Hudson MP, Armstrong PW, Ruzyllo W, et al. Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction: results of the PREMIER (Prevention of Myocardial Infarction Early Remodeling) trial. J Am Coll Cardiol. 2006; 48: 15-20.
24. Jones JH. Resource book for the design of animal exercise protocols. Am J Vet Res. 2007; 68: 583
25. Moshal KS, Kumar M, Tyagi N, et al. Restoration of contractility in hyperhomocysteinemia by cardiac-specific deletion of NMDA-R1. Am J Physiol Heart Circ Physiol. 2009; 296: H887-92.
26. Ellman GL, Courtney KD, Andres V Jr, et al. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 1961; 7: 88-95.
27. Chaturvedi P, Kalani A, Givvimani S, et al. Differential regulation of DNA methylation versus histone acetylation in cardiomyocytes during HHcy in vitro and in vivo: an epigenetic mechanism. Physiol Genomics. 2014; 46: 245-55.
28. Barile L, Gherghiceanu M, Popescu LM, et al. Ultrastructural evidence of exosome secretion by progenitor cells in adult mouse myocardium and adult human cardiospheres. J Biomed Biotechnol. 2012; 2012: 354605.
29. Waldenstrom A, Genneback N, Hellman U, et al. Cardiomyocyte microvesicles contain DNA/RNA and convey biological messages to target cells. PLoS ONE. 2012; 7: e34653.
30. Caby MP, Lankar D, Vincendeau-Scherrer C, et al. Exosomal-like vesicles are present in human blood plasma. Int Immunol. 2005; 17: 879-87.
31. Lasser C, Eldh M, Lotvall J. Isolation and characterization of RNA-containing exosomes. J Vis Exp. 2012; e3037.
32. Huang X, Yuan T, Tschannen M, et al. Characterization of human plasma-derived exosomal RNAs by deep sequencing. BMC Genom. 2013; 14: 319.
33. Aswad H, Forterre A, Wiklander OP, et al. Exosomes participate in the alteration of muscle homeostasis during lipid-induced insulin resistance in mice. Diabetologia. 2014; 57: 2155-64.
34. Winchester L, Veeranki S, Givvimani S, et al. Exercise mitigates the adverse effects of hyperhomocysteinemia on macrophages, MMP-9, skeletal muscle, and white adipocytes. Can J Physiol Pharmacol. 2014; 92: 575-82.
35. Tyagi SC, Joshua IG. Exercise and nutrition in myocardial matrix metabolism, remodeling, regeneration, epigenetics, microcirculation, and muscle. Can J Physiol Pharmacol. 2014; 92: 521-3.
36. Tyagi SC, Ratajska A, Weber KT. Myocardial matrix metalloproteinase(s): localization and activation. Mol Cell Biochem. 1993; 126: 49-59.
37. Tyagi SC, Kumar S, Voelker DJ, et al. Differential gene expression of extracellular matrix components in dilated cardiomyopathy. J Cell Biochem. 1996; 63: 185-98.
38. Tsai WC, Liang FC, Cheng JW, et al. High glucose concentration up-regulates the expression of matrix metalloproteinase-9 and -13 in tendon cells. BMC Musculoskelet Disord. 2013; 14: 255.
39. Chen KC, Wang YS, Hu CY, et al. OxLDL up-regulates microRNA-29b, leading to epigenetic modifications of MMP-2/MMP-9 genes: a novel mechanism for cardiovascular diseases. FASEB J. 2011; 25: 1718-28.